Corcept Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Corcept Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About CORT

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. 

CEO
Joseph K. Belanoff
CEOJoseph K. Belanoff
Employees
730
Employees730
Headquarters
Redwood City, California
HeadquartersRedwood City, California
Founded
1998
Founded1998
Employees
730
Employees730

CORT Key Statistics

Market cap
6.46B
Market cap6.46B
Price-Earnings ratio
170.54
Price-Earnings ratio170.54
Dividend yield
Dividend yield
Average volume
1.23M
Average volume1.23M
High today
$60.95
High today$60.95
Low today
$59.54
Low today$59.54
Open price
$60.00
Open price$60.00
Volume
464.97K
Volume464.97K
52 Week high
$91.00
52 Week high$91.00
52 Week low
$28.66
52 Week low$28.66

Stock Snapshot

As of today, Corcept Therapeutics(CORT) shares are valued at $60.22. The company's market cap stands at 6.46B, with a P/E ratio of 170.54.

As of 2026-05-22, Corcept Therapeutics(CORT) stock has fluctuated between $59.54 and $60.95. The current price stands at $60.22, placing the stock +1.1% above today's low and -1.2% off the high.

Corcept Therapeutics(CORT) shares are trading with a volume of 464.97K, against a daily average of 1.23M.

During the past year, Corcept Therapeutics(CORT) stock moved between $28.66 at its lowest and $91.00 at its peak.

During the past year, Corcept Therapeutics(CORT) stock moved between $28.66 at its lowest and $91.00 at its peak.

CORT News

Simply Wall St 23h
A Look At Corcept Therapeutics Valuation After Its Strong Recent Share Price Rebound

Advertisement Recent return profile and business snapshot Corcept Therapeutics (CORT) has drawn fresh attention after a strong recent share price run, with th...

A Look At Corcept Therapeutics Valuation After Its Strong Recent Share Price Rebound

Analyst ratings

83%

of 6 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

People also own

Based on the portfolios of people who own CORT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.